AU Stock MarketDetailed Quotes

Imricor Medical Systems Inc (IMR)

Watchlist
  • 1.765
  • +0.040+2.32%
20min DelayNot Open May 13 16:00 AET
623.71MMarket Cap-14.83P/E (Static)

Imricor Medical Systems Inc (IMR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2025
(FY)Dec 30, 2024
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
(FY)Dec 30, 2020
(FY)Dec 30, 2019
Total revenue
-69.53%292.31K
55.86%959.42K
-24.56%615.57K
17.20%816.01K
-0.84%696.27K
9.76%702.16K
639.7K
Operating revenue
-69.53%292.31K
55.86%959.42K
-24.56%615.57K
17.20%816.01K
-0.84%696.27K
9.76%702.16K
--639.7K
Cost of revenue
23.48%2.33M
8.79%1.88M
-26.10%1.73M
-9.62%2.34M
135.69%2.59M
191.45%1.1M
377.37K
Gross profit
-120.05%-2.03M
17.18%-924.12K
26.92%-1.12M
19.47%-1.53M
-376.76%-1.9M
-251.59%-397.67K
262.34K
Operating expense
33.78%21.59M
-1.94%16.14M
-0.05%16.46M
-14.00%16.47M
58.16%19.15M
-6.96%12.11M
13.01M
Selling and administrative expenses
33.50%9.6M
-8.02%7.19M
0.42%7.82M
-10.37%7.79M
44.50%8.69M
87.38%6.01M
--3.21M
-Selling and marketing expense
89.27%4.3M
-16.83%2.27M
-2.60%2.73M
-2.22%2.8M
70.37%2.87M
193.80%1.68M
--573.06K
-General and administrative expense
7.74%5.3M
-3.29%4.92M
2.12%5.09M
-14.39%4.98M
34.45%5.82M
64.25%4.33M
--2.64M
Research and development costs
36.38%11.16M
3.29%8.18M
-0.33%7.92M
-17.87%7.95M
74.45%9.68M
54.01%5.55M
--3.6M
Depreciation amortization depletion
6.76%798.72K
5.74%748.17K
-0.69%707.55K
3.39%712.49K
30.49%689.11K
105.24%528.09K
--257.3K
-Depreciation and amortization
6.76%798.72K
5.74%748.17K
-0.69%707.55K
3.39%712.49K
30.49%689.11K
105.24%528.09K
--257.3K
Other operating expenses
85.24%34.6K
45.97%18.68K
-43.14%12.8K
-76.49%22.51K
368.97%95.74K
-99.66%20.42K
--5.95M
Operating profit
-38.45%-23.62M
2.91%-17.06M
2.33%-17.58M
14.49%-18M
-68.29%-21.04M
1.93%-12.5M
-12.75M
Net non-operating interest income (expenses)
394.89%1.18M
1,477.41%237.65K
121.55%15.07K
24.10%-69.92K
66.06%-92.12K
73.31%-271.4K
-1.02M
Non-operating interest income
357.98%1.18M
308.99%257.72K
-41.65%63.01K
545.73%108K
-42.80%16.73K
111.01%29.24K
--13.86K
Non-operating interest expense
-79.22%4.17K
-58.15%20.07K
-73.05%47.95K
63.45%177.92K
-63.79%108.85K
-70.83%300.64K
--1.03M
Other net income (expenses)
73.05%-3.67M
-135.83%-13.61M
-153,646.13%-5.77M
-100.53%-3.76K
460.25%714.72K
-191.79%-198.4K
216.14K
Other non-operating income (expenses)
73.05%-3.67M
-135.83%-13.61M
-153,646.13%-5.77M
-100.53%-3.76K
460.25%714.72K
-191.79%-198.4K
--216.14K
Income before tax
14.73%-25.32M
-31.23%-29.69M
-30.36%-22.63M
12.04%-17.36M
-58.54%-19.73M
6.38%-12.45M
-13.29M
Income tax
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
14.73%-25.32M
-31.23%-29.69M
-30.36%-22.63M
12.04%-17.36M
-58.54%-19.73M
6.38%-12.45M
-13.29M
Net income continuous operations
14.73%-25.32M
-31.23%-29.69M
-30.36%-22.63M
12.04%-17.36M
-58.54%-19.73M
6.38%-12.45M
---13.29M
Noncontrolling interests
Net income attributable to the company
14.73%-25.32M
-31.23%-29.69M
-30.36%-22.63M
12.04%-17.36M
-58.54%-19.73M
6.38%-12.45M
-13.29M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
14.73%-25.32M
-31.23%-29.69M
-30.36%-22.63M
12.04%-17.36M
-58.54%-19.73M
6.38%-12.45M
-13.29M
Diluted earnings per share
38.46%-0.08
4.12%-0.13
-16.67%-0.1356
20.00%-0.1162
-36.36%-0.1453
50.00%-0.1065
-0.2131
Basic earnings per share
38.46%-0.08
4.12%-0.13
-16.67%-0.1356
20.00%-0.1162
-36.36%-0.1453
50.00%-0.1065
-0.2131
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2025(FY)Dec 30, 2024(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021(FY)Dec 30, 2020(FY)Dec 30, 2019
Total revenue -69.53%292.31K55.86%959.42K-24.56%615.57K17.20%816.01K-0.84%696.27K9.76%702.16K639.7K
Operating revenue -69.53%292.31K55.86%959.42K-24.56%615.57K17.20%816.01K-0.84%696.27K9.76%702.16K--639.7K
Cost of revenue 23.48%2.33M8.79%1.88M-26.10%1.73M-9.62%2.34M135.69%2.59M191.45%1.1M377.37K
Gross profit -120.05%-2.03M17.18%-924.12K26.92%-1.12M19.47%-1.53M-376.76%-1.9M-251.59%-397.67K262.34K
Operating expense 33.78%21.59M-1.94%16.14M-0.05%16.46M-14.00%16.47M58.16%19.15M-6.96%12.11M13.01M
Selling and administrative expenses 33.50%9.6M-8.02%7.19M0.42%7.82M-10.37%7.79M44.50%8.69M87.38%6.01M--3.21M
-Selling and marketing expense 89.27%4.3M-16.83%2.27M-2.60%2.73M-2.22%2.8M70.37%2.87M193.80%1.68M--573.06K
-General and administrative expense 7.74%5.3M-3.29%4.92M2.12%5.09M-14.39%4.98M34.45%5.82M64.25%4.33M--2.64M
Research and development costs 36.38%11.16M3.29%8.18M-0.33%7.92M-17.87%7.95M74.45%9.68M54.01%5.55M--3.6M
Depreciation amortization depletion 6.76%798.72K5.74%748.17K-0.69%707.55K3.39%712.49K30.49%689.11K105.24%528.09K--257.3K
-Depreciation and amortization 6.76%798.72K5.74%748.17K-0.69%707.55K3.39%712.49K30.49%689.11K105.24%528.09K--257.3K
Other operating expenses 85.24%34.6K45.97%18.68K-43.14%12.8K-76.49%22.51K368.97%95.74K-99.66%20.42K--5.95M
Operating profit -38.45%-23.62M2.91%-17.06M2.33%-17.58M14.49%-18M-68.29%-21.04M1.93%-12.5M-12.75M
Net non-operating interest income (expenses) 394.89%1.18M1,477.41%237.65K121.55%15.07K24.10%-69.92K66.06%-92.12K73.31%-271.4K-1.02M
Non-operating interest income 357.98%1.18M308.99%257.72K-41.65%63.01K545.73%108K-42.80%16.73K111.01%29.24K--13.86K
Non-operating interest expense -79.22%4.17K-58.15%20.07K-73.05%47.95K63.45%177.92K-63.79%108.85K-70.83%300.64K--1.03M
Other net income (expenses) 73.05%-3.67M-135.83%-13.61M-153,646.13%-5.77M-100.53%-3.76K460.25%714.72K-191.79%-198.4K216.14K
Other non-operating income (expenses) 73.05%-3.67M-135.83%-13.61M-153,646.13%-5.77M-100.53%-3.76K460.25%714.72K-191.79%-198.4K--216.14K
Income before tax 14.73%-25.32M-31.23%-29.69M-30.36%-22.63M12.04%-17.36M-58.54%-19.73M6.38%-12.45M-13.29M
Income tax 0000000
Earnings from equity interest net of tax
Net income 14.73%-25.32M-31.23%-29.69M-30.36%-22.63M12.04%-17.36M-58.54%-19.73M6.38%-12.45M-13.29M
Net income continuous operations 14.73%-25.32M-31.23%-29.69M-30.36%-22.63M12.04%-17.36M-58.54%-19.73M6.38%-12.45M---13.29M
Noncontrolling interests
Net income attributable to the company 14.73%-25.32M-31.23%-29.69M-30.36%-22.63M12.04%-17.36M-58.54%-19.73M6.38%-12.45M-13.29M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 14.73%-25.32M-31.23%-29.69M-30.36%-22.63M12.04%-17.36M-58.54%-19.73M6.38%-12.45M-13.29M
Diluted earnings per share 38.46%-0.084.12%-0.13-16.67%-0.135620.00%-0.1162-36.36%-0.145350.00%-0.1065-0.2131
Basic earnings per share 38.46%-0.084.12%-0.13-16.67%-0.135620.00%-0.1162-36.36%-0.145350.00%-0.1065-0.2131
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More